AI-powered evaluation using the Model Context Optimization BS Detection Framework, based solely on publicly available website content.
Based on 784 businesses audited.
FARXIGA has 15.7 points less BS than the average for Medical Devices, Pharma & Biotech.
Medical Devices, Pharma & Biotech BS: FARXIGA (farxiga.com)
FARXIGA.com is a high-substance, low-fluff pharmaceutical portal that sacrifices digital authority markers for legal compliance. It is factually dense but technically invisible to structured search, relying entirely on the weight of its clinical data rather than modern trust-building signals.
Implement comprehensive Physician and Drug schema.org structured data to link the brand to its FDA-approved indications. Replace empty H1 and H2 placeholders on indication-specific pages with keyword-rich condition descriptions to fix the technical hierarchy. Add direct outbound links to published clinical trial results on PubMed or ClinicalTrials.gov to provide a legitimate proof path beyond internal PDFs.
The site exhibits high information density with a low ratio of fluff to substance. Body text contains specific clinical metrics such as ‘A1C reduction of up to 2.1%’ and references to technical diagnostic tests like ‘eGFR’ and ‘UACR.’ Headings are largely functional rather than hyperbolic, though the H1 ‘Welcome to FARXIGA’ is structurally weak.
AI only sees the HTML that arrives on first response — everything else is invisible. Expose your real text only footprint and find out which parts of your site never reach an AI crawler at all.
There is zero semantic drift between the homepage signal and sub-page substance. The homepage H1 and meta-description promise coverage of CKD, Heart Failure, and T2D, and each strategically selected sub-page delivers deep-dive content specifically for those indications without shifting target audiences or value propositions.
Move beyond vague agency reporting and visualize your surgical implementation plan. Order an Executive SEO Strategy and stop relying on superficial keyword tracking.
While the site uses the word ‘proven’ 12 times across the crawled pages, it fails the proof path test with a proof_links_count of 0. It relies on internal ‘Prescribing Information’ and ‘Medication Guides’ rather than linking to external peer-reviewed studies or ClinicalTrials.gov identifiers, creating a circular trust loop typical of big pharma portals.
Proof density is high regarding clinical outcomes (e.g., ‘1 in 8 deaths associated with heart failure’) but low regarding external verification. The site provides 8+ instances of specific evidence per page, yet these are presented as internal facts rather than verifiable external proof points.
For a high volume editorial domain example, open the Search Engine Journal Semantic HTML audit. View the SEJ Semantic HTML Audit to see how template drift and structural noise impact AI chunking.
The site matches several industry clichés such as ‘clinical trial data’ and ‘trusted by healthcare professionals,’ but avoids the most egregious value prop cliches. The ‘Pay $0’ offer is a common industry pattern, yet the high degree of specificity regarding medical indications prevents the site from feeling like a generic commodity template.
A significant authority gap exists due to the total absence of JSON-LD schema (schema_json is null) and a lack of named medical experts or contributors. Furthermore, technical credibility is hampered by poor heading hierarchy on sub-pages where H1 and H2 tags are occasionally empty or missing in the structured crawl data.
The marketing tone is restrained and clinically focused. Performance claims like ‘reduce the risk of cardiovascular death’ are backed by specific situational parameters (e.g., ‘in adults with heart failure’) rather than vague breakthrough promises, though the lack of direct data citations remains a minor disconnect.
Medical Devices, Pharma & Biotech BS: FARXIGA (farxiga.com)
The content perfectly aligns with the Pharmaceuticals category, specifically focusing on SGLT2 inhibitors for chronic kidney disease, heart failure, and type 2 diabetes. The presence of extensive Important Safety Information (ISI) and commercial eligibility terms is characteristic of the highly regulated US pharmaceutical industry.
Every pillar of machine readability depends on one foundation: explicit, verifiable entity definitions. Explore the Structured Data Technical Framework to understand how identity, relationships, and @id anchors form the base layer of AI interpretation.
“The score of 25 is primarily generated by Step 3 (Trust and Proof) and Step 5 (Identity and Authority). The lack of external proof paths and total absence of structured schema represent the only significant bullshit patterns on an otherwise substance-heavy medical site.”
Analysis Disclosure & Source Attribution
Snapshot Date: May 30, 2026
Purpose: This data is presented under “Fair Use” / “Educational Exception” for the purpose of forensic semantic analysis, allowing users to see how machine logic interprets digital signals.
Machine Perception Notice: This evaluation is generated by machine-read logic (MRL). The AI interprets the “Digital Ghost” of a website (code, metadata, and semantic structures), which may differ from what a human sees at the same moment. This is an automated technical diagnostic and not a statement of fact or human opinion regarding the real-world integrity or legitimacy of the business. Any missing or inaccessible elements in the snapshot are treated as machine-read signals, reflecting AI rendering limitations rather than intentional omission.
Notice to the Evaluated Business: This analysis is part of a non-adversarial audit. The results are intended as professional feedback to help improve machine-readability and authority signals. Any company can use these insights for free. When content is updated, a fresh audit can be requested at any time to reflect the current state.
To All Users: You are encouraged to visit the live site at FARXIGA to view the most current version of their content and see directly what the company offers.